Strong Association of De Novo Copy Number Mutations with Autism

We tested the hypothesis that de novo copy number variation (CNV) is associated with autism spectrum disorders (ASDs). We performed comparative genomic hybridization (CGH) on the genomic DNA of patients and unaffected subjects to detect copy number variants not present in their respective parents. C...

Full description

Saved in:
Bibliographic Details
Published inScience (American Association for the Advancement of Science) Vol. 316; no. 5823; pp. 445 - 449
Main Authors Sebat, Jonathan, Lakshmi, B, Malhotra, Dheeraj, Troge, Jennifer, Lese-Martin, Christa, Walsh, Tom, Yamrom, Boris, Yoon, Seungtai, Krasnitz, Alex, Kendall, Jude, Leotta, Anthony, Pai, Deepa, Zhang, Ray, Lee, Yoon-Ha, Hicks, James, Spence, Sarah J, Lee, Annette T, Puura, Kaija, Lehtimäki, Terho, Ledbetter, David, Gregersen, Peter K, Bregman, Joel, Sutcliffe, James S, Jobanputra, Vaidehi, Chung, Wendy, Warburton, Dorothy, King, Mary-Claire, Skuse, David, Geschwind, Daniel H, Gilliam, T. Conrad, Ye, Kenny, Wigler, Michael
Format Journal Article
LanguageEnglish
Published Washington, DC American Association for the Advancement of Science 20.04.2007
The American Association for the Advancement of Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We tested the hypothesis that de novo copy number variation (CNV) is associated with autism spectrum disorders (ASDs). We performed comparative genomic hybridization (CGH) on the genomic DNA of patients and unaffected subjects to detect copy number variants not present in their respective parents. Candidate genomic regions were validated by higher-resolution CGH, paternity testing, cytogenetics, fluorescence in situ hybridization, and microsatellite genotyping. Confirmed de novo CNVs were significantly associated with autism (P = 0.0005). Such CNVs were identified in 12 out of 118 (10%) of patients with sporadic autism, in 2 out of 77 (3%) of patients with an affected first-degree relative, and in 2 out of 196 (1%) of controls. Most de novo CNVs were smaller than microscopic resolution. Affected genomic regions were highly heterogeneous and included mutations of single genes. These findings establish de novo germline mutation as a more significant risk factor for ASD than previously recognized.
Bibliography:http://www.scienceonline.org/
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
These authors contributed equally to this work.
ISSN:0036-8075
1095-9203
1095-9203
DOI:10.1126/science.1138659